Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion
MarketWatch·2025-11-03 13:27Kenvue股价表现 - Kenvue股票在近期创下历史新低后迎来史上最佳单日表现[1] Kimberly-Clark股价表现 - Kimberly-Clark股票价格出现大幅下跌[1]
MarketWatch·2025-11-03 13:27 MarketWatch·2025-11-03 13:27